Wnt5a and ROR1 activate non-canonical Wnt signaling via RhoA in TCF3-PBX1 acute lymphoblastic leukemia and highlight new treatment strategies via Bcl-2 co-targeting

H. Karvonen; R. Perttilä; W. Niininen; V. Hautanen; H. Barker; A. Murumägi; C.A. Heckman; D Ungureanu

doi:10.1038/s41388-018-0670-9

Wnt5a and ROR1 activate non-canonical Wnt signaling via RhoA in TCF3-PBX1 acute lymphoblastic leukemia and highlight new treatment strategies via Bcl-2 co-targeting

H. Karvonen, R. Perttilä, W. Niininen, V. Hautanen, H. Barker, A. Murumägi, C.A. Heckman, D Ungureanu

Research output: Contribution to journal › Article › Scientific › peer-review

44 Citations (Scopus)

Original language	English
Pages (from-to)	3288-3300
Journal	Oncogene
Volume	38
DOIs	https://doi.org/10.1038/s41388-018-0670-9
Publication status	Published - 2019
Publication type	A1 Journal article-refereed

Publication forum classification

Publication forum level 2

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1038/s41388-018-0670-9

Cite this

@article{db9f570f5e3946b2b8a896c611b692b3,

title = "Wnt5a and ROR1 activate non-canonical Wnt signaling via RhoA in TCF3-PBX1 acute lymphoblastic leukemia and highlight new treatment strategies via Bcl-2 co-targeting",

author = "H. Karvonen and R. Perttil{\"a} and W. Niininen and V. Hautanen and H. Barker and A. Murum{\"a}gi and C.A. Heckman and D Ungureanu",

year = "2019",

doi = "10.1038/s41388-018-0670-9",

language = "English",

volume = "38",

pages = "3288--3300",

journal = "Oncogene",

issn = "0950-9232",

publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - Wnt5a and ROR1 activate non-canonical Wnt signaling via RhoA in TCF3-PBX1 acute lymphoblastic leukemia and highlight new treatment strategies via Bcl-2 co-targeting

AU - Karvonen, H.

AU - Perttilä, R.

AU - Niininen, W.

AU - Hautanen, V.

AU - Barker, H.

AU - Murumägi, A.

AU - Heckman, C.A.

AU - Ungureanu, D

PY - 2019

Y1 - 2019

U2 - 10.1038/s41388-018-0670-9

DO - 10.1038/s41388-018-0670-9

M3 - Article

SN - 0950-9232

VL - 38

SP - 3288

EP - 3300

JO - Oncogene

JF - Oncogene

ER -